Generic & Specialty Pharmaceuticals
Pfizer/BioNTech say 3 COVID shots elicit good response in children under 5
By Michael Erman (Reuters) -Drugmakers Pfizer Inc and BioNTech SE said on Monday that three doses of their COVID-19 vaccine...
Read more
When Africans asked for COVID shots, they didn’t get them. Now they don’t want them
By Edward McAllister and Cooper Inveen DAKAR/ACCRA (Reuters) - It's noisy inside the Mamprobi clinic in Accra as kids clamber...
Read more
South Africa’s Aspen COVID-19 vaccine plant risks closure after no orders-executive
By Tim Cocks JOHANNESBURG (Reuters) - Africa's first COVID-19 vaccination plant, touted last year as a trailblazer for an under-vaccinated...
Read more
Japan’s Shionogi says COVID-19 pill shows rapid clearance of virus
TOKYO (Reuters) - An experimental treatment from Shionogi & Co Ltd has shown rapid clearance of the virus that causes...
Read more
Pfizer/BioNTech say booster dose increases protection vs Omicron in kids aged 5-11
By Mrinalika Roy (Reuters) -A third dose of the COVID-19 vaccine from Pfizer Inc and BioNTech produced significant protection against...
Read more
Thai politician indicted for royal insult over vaccine speech
BANGKOK (Reuters) - A prominent Thai politician faces up to 20 years in prison following his indictment on Monday for...
Read more
Chinese national sentenced to U.S. prison after pleading guilty to stealing trade secrets
By Kanishka Singh WASHINGTON (Reuters) - A Chinese national has been sentenced to 29 months in prison after pleading guilty...
Read more
Analysis-Governments want COVID vaccine developers to aim higher in hunt for better shots
By Ludwig Burger and Emilio Parodi (Reuters) - As governments prepare to live with COVID-19, some are questioning how much...
Read more
EU sets up distribution centres on Ukraine border for refugees needing care
By Ludwig Burger (Reuters) - The European Union is setting up centres on its borders to Ukraine to receive and...
Read more
German health minister urges people at risk to get second COVID booster
BERLIN (Reuters) - Germany's health minister on Friday urged people over age 60 with risk factors such as high blood...
Read moreRussian health regulator says medicine shortage due to spike in demand
(Reuters) - Russian healthcare regulator Roszdravnadzor on Friday said medicine shortages were due to "artificially" higher demand and that suppliers...
Read more
Europe begins reviewing application for AstraZeneca COVID drug
(Reuters) - Europe's drug regulator said on Tuesday it had begun reviewing AstraZeneca Plc's application for antibody-based COVID-19 therapy, a...
Read more
China approves five COVID-19 antigen kits for self-testing – CCTV
SHANGHAI (Reuters) - China has granted approval to five COVID-19 antigen kits made by local companies to be used for...
Read more
Analysis-Drugmakers look to help Ukrainians in drug trials after Russian invasion
By Manas Mishra (Reuters) - The Russian invasion of Ukraine has left drugmakers scrambling to find ways for patients enrolled...
Read more
South Africa risks destroying 100,000 vaccine doses by end-March due to slow uptake
JOHANNESBURG (Reuters) - About 100,000 doses of Pfizer's COVID-19 vaccine are at risk of being destroyed by the end of...
Read more
Pfizer to provide 10 million courses of COVID pill to developing countries -the Global Fund
By Michael Erman (Reuters) - Pfizer Inc is expected to provide around 10 million courses of its highly effective COVID-19...
Read more
Swiss reject ban on animal testing in referendum
By John Revill ZURICH (Reuters) - Swiss voters rejected a proposal by animal rights activists to make Switzerland the first...
Read more
Swiss to vote on becoming first country to ban animal testing
By John Revill ZURICH (Reuters) - Switzerland votes on Sunday whether to become the first country to completely ban medical...
Read more
Australia suffers deadliest day of pandemic, expands booster eligibility
SYDNEY (Reuters) -Australia suffered its deadliest day of the COVID-19 pandemic on Friday with nearly 100 deaths, but several large...
Read more
As Omicron ebbs, England revives Plan A: living with COVID
By Alistair Smout and Elizabeth Piper LONDON (Reuters) -After an uncomfortable but relatively brief return to coronavirus restrictions triggered by...
Read more